Acadia Healthcare Company, Inc. $ACHC Shares Bought by Strs Ohio

Strs Ohio raised its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 15,846.7% during the first quarter, HoldingsChannel reports. The firm owned 347,637 shares of the company’s stock after buying an additional 345,457 shares during the quarter. Strs Ohio’s holdings in Acadia Healthcare were worth $8,131,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Wellington Management Group LLP raised its stake in Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after buying an additional 2,350,760 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after acquiring an additional 3,815,471 shares in the last quarter. Abrams Bison Investments LLC increased its holdings in shares of Acadia Healthcare by 22.3% in the 3rd quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after acquiring an additional 800,000 shares during the last quarter. UBS Group AG raised its position in shares of Acadia Healthcare by 8.8% during the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after acquiring an additional 350,484 shares in the last quarter. Finally, Jefferies Financial Group Inc. acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth about $47,960,000.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $31.91 on Monday. The stock’s 50-day moving average price is $25.70 and its 200 day moving average price is $21.29. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $2.93 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 10.64 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $32.82.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company’s revenue was up 7.6% on a year-over-year basis. During the same period last year, the business posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Guggenheim upped their price target on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Cantor Fitzgerald boosted their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Royal Bank Of Canada upped their target price on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a research report on Monday, May 4th. Finally, Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Acadia Healthcare has an average rating of “Hold” and a consensus target price of $26.85.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.